Ep. 171 - 2Q Markets Preview, Abortion Drug Rulings, Gilead Oncology
BioCentury This Week
00:00
The Upturn in Biotech Investments
There are a lot of people out there who sort of feel that this is an opportunity to separate the wheat from the chaff perhaps and that the really good innovation will still get funded. I don't know that we've had one where we had a tailwind of so much funding to this degree going into the downturn but at the same time we've never had this degree of innovation in biotech. We just need to get a bit of momentum going here before I think we can start talking about a recovery.
Transcript
Play full episode
